• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌病:非编码RNA的作用

Cardiomyopathies: The Role of Non-Coding RNAs.

作者信息

Carabetta Nicole, Siracusa Chiara, Leo Isabella, Panuccio Giuseppe, Strangio Antonio, Sabatino Jolanda, Torella Daniele, De Rosa Salvatore

机构信息

Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy.

Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy.

出版信息

Noncoding RNA. 2024 Oct 23;10(6):53. doi: 10.3390/ncrna10060053.

DOI:10.3390/ncrna10060053
PMID:39449507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11503404/
Abstract

Cardiomyopathies are the structural and functional disorders of the myocardium. Etiopathogenesis is complex and involves an interplay of genetic, environmental, and lifestyle factors eventually leading to myocardial abnormalities. It is known that non-coding (Nc) RNAs, including micro (mi)-RNAs and long non-coding (lnc) RNAs, play a crucial role in regulating gene expression. Several studies have explored the role of miRNAs in the development of various pathologies, including heart diseases. In this review, we analyzed various patterns of ncRNAs expressed in the most common cardiomyopathies: dilated cardiomyopathy, hypertrophic cardiomyopathy and arrhythmogenic cardiomyopathy. Understanding the role of different ncRNAs implicated in cardiomyopathic processes may contribute to the identification of potential therapeutic targets and novel risk stratification models based on gene expression. The analysis of ncRNAs may also be helpful to unveil the molecular mechanisms subtended to these diseases.

摘要

心肌病是心肌的结构和功能紊乱。病因发病机制复杂,涉及遗传、环境和生活方式因素的相互作用,最终导致心肌异常。已知非编码(Nc)RNA,包括微小(mi)RNA和长链非编码(lnc)RNA,在调节基因表达中起关键作用。多项研究探讨了miRNA在包括心脏病在内的各种病理过程发展中的作用。在本综述中,我们分析了在最常见的心肌病(扩张型心肌病、肥厚型心肌病和致心律失常性心肌病)中表达的各种ncRNA模式。了解参与心肌病过程的不同ncRNA的作用,可能有助于确定潜在的治疗靶点以及基于基因表达的新型风险分层模型。对ncRNA的分析也可能有助于揭示这些疾病背后的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/11503404/aa85c8a0a76e/ncrna-10-00053-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/11503404/1c6c12a9f310/ncrna-10-00053-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/11503404/aa85c8a0a76e/ncrna-10-00053-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/11503404/1c6c12a9f310/ncrna-10-00053-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3096/11503404/aa85c8a0a76e/ncrna-10-00053-g002.jpg

相似文献

1
Cardiomyopathies: The Role of Non-Coding RNAs.心肌病:非编码RNA的作用
Noncoding RNA. 2024 Oct 23;10(6):53. doi: 10.3390/ncrna10060053.
2
Epigenetic regulation in myocardial infarction: Non-coding RNAs and exosomal non-coding RNAs.心肌梗死中的表观遗传调控:非编码RNA与外泌体非编码RNA
Front Cardiovasc Med. 2022 Nov 10;9:1014961. doi: 10.3389/fcvm.2022.1014961. eCollection 2022.
3
MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy.肥厚型、致心律失常型和扩张型心肌病中的微小RNA
Diagnostics (Basel). 2021 Sep 19;11(9):1720. doi: 10.3390/diagnostics11091720.
4
The Emerging Role of Epigenetics in Therapeutic Targeting of Cardiomyopathies.表观遗传学在心肌病治疗靶点中的新兴作用。
Int J Mol Sci. 2021 Aug 13;22(16):8721. doi: 10.3390/ijms22168721.
5
Role of non-coding RNAs as biomarkers of deleterious cardiovascular effects in sepsis.非编码 RNA 作为脓毒症有害心血管效应生物标志物的作用。
Prog Cardiovasc Dis. 2021 Sep-Oct;68:70-77. doi: 10.1016/j.pcad.2021.07.005. Epub 2021 Jul 13.
6
Non-coding RNA in Ischemic and Non-ischemic Cardiomyopathy.非编码 RNA 在缺血性和非缺血性心肌病中的作用。
Curr Cardiol Rep. 2018 Sep 26;20(11):115. doi: 10.1007/s11886-018-1055-y.
7
Targeting non-coding RNAs in sEVs: The biological functions and potential therapeutic strategy of diabetic cardiomyopathy.靶向外泌体中的非编码 RNA:糖尿病心肌病的生物学功能及潜在治疗策略。
Biomed Pharmacother. 2023 Jul;163:114836. doi: 10.1016/j.biopha.2023.114836. Epub 2023 May 8.
8
Inherited Cardiomyopathies and the Role of Mutations in Non-coding Regions of the Genome.遗传性心肌病与基因组非编码区突变的作用
Front Cardiovasc Med. 2018 Jun 26;5:77. doi: 10.3389/fcvm.2018.00077. eCollection 2018.
9
Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome.循环非编码RNA在代谢性疾病中的临床相关性:重点关注肥胖、糖尿病、心血管疾病和代谢综合征。
Genes Dis. 2022 Jun 3;10(6):2393-2413. doi: 10.1016/j.gendis.2022.05.022. eCollection 2023 Nov.
10
Cardiomyopathies: An Overview.心肌病:概述。
Int J Mol Sci. 2021 Jul 19;22(14):7722. doi: 10.3390/ijms22147722.

引用本文的文献

1
Role of thrombus-derived exosomal lncRNA LOC101928697 in regulating endothelial function via FUS protein interaction in myocardial infarction.血栓衍生的外泌体长链非编码RNA LOC101928697在心肌梗死中通过与FUS蛋白相互作用调节内皮功能的作用
Sci Prog. 2025 Jul-Sep;108(3):368504251372111. doi: 10.1177/00368504251372111. Epub 2025 Sep 3.
2
Sevoflurane reduces cardiomyocyte injury in a hypoxia/reoxygenation model of cardiomyocytes through the linc01278/miR-134-5pt regulatory axis.七氟醚通过linc01278/miR-134-5p调控轴减轻心肌细胞缺氧/复氧模型中的心肌细胞损伤。
BMC Pharmacol Toxicol. 2025 Apr 14;26(1):83. doi: 10.1186/s40360-025-00909-z.

本文引用的文献

1
Changes of intracardiac flow dynamics measured by HyperDoppler in patients with aortic stenosis.用超多普勒测量主动脉瓣狭窄患者的心内血流动力学变化。
Eur Heart J Open. 2024 Aug 8;4(5):oeae069. doi: 10.1093/ehjopen/oeae069. eCollection 2024 Sep.
2
Role of myocardial microRNAs in the long-term ventricular remodelling of patients with aortic stenosis.心肌微小RNA在主动脉瓣狭窄患者长期心室重构中的作用
Eur Heart J Open. 2024 Jul 24;4(4):oeae060. doi: 10.1093/ehjopen/oeae060. eCollection 2024 Jul.
3
Identification of Potential lncRNA-miRNA-mRNA Regulatory Network Contributing to Arrhythmogenic Right Ventricular Cardiomyopathy.
导致致心律失常性右室心肌病的潜在lncRNA-miRNA-mRNA调控网络的鉴定
J Cardiovasc Dev Dis. 2024 May 30;11(6):168. doi: 10.3390/jcdd11060168.
4
LncRNA DCRT Protects Against Dilated Cardiomyopathy by Preventing NDUFS2 Alternative Splicing by Binding to PTBP1.长链非编码 RNA DCRT 通过与 PTBP1 结合防止 NDUFS2 可变剪接来保护心肌扩张。
Circulation. 2024 Sep 24;150(13):1030-1049. doi: 10.1161/CIRCULATIONAHA.123.067861. Epub 2024 Jun 6.
5
Unveiling MiRNA-124 as a biomarker in hypertrophic cardiomyopathy: An innovative approach using machine learning and intelligent data analysis.揭示 miRNA-124 作为肥厚型心肌病的生物标志物:一种使用机器学习和智能数据分析的创新方法。
Int J Cardiol. 2024 Sep 1;410:132220. doi: 10.1016/j.ijcard.2024.132220. Epub 2024 May 28.
6
Fibroblast-localized lncRNA CFIRL promotes cardiac fibrosis and dysfunction in dilated cardiomyopathy.成纤维细胞特异性长链非编码 RNA CFIRL 促进扩张型心肌病中的心脏纤维化和功能障碍。
Sci China Life Sci. 2024 Jun;67(6):1155-1169. doi: 10.1007/s11427-023-2452-2. Epub 2024 Feb 28.
7
Transcriptomic Analyses and Experimental Validation Identified Immune-Related lncRNA-mRNA Pair - Regulating the Progression of Hypertrophic Cardiomyopathy.转录组分析与实验验证确定了免疫相关lncRNA-mRNA对——调控肥厚型心肌病的进展
Int J Mol Sci. 2024 Feb 29;25(5):2816. doi: 10.3390/ijms25052816.
8
Integrated analysis of differentially expressed genes and miRNA expression profiles in dilated cardiomyopathy.扩张型心肌病中差异表达基因与miRNA表达谱的综合分析
Heliyon. 2024 Feb 12;10(4):e25569. doi: 10.1016/j.heliyon.2024.e25569. eCollection 2024 Feb 29.
9
LncRNA CHKB-DT Downregulation Enhances Dilated Cardiomyopathy Through ALDH2.长链非编码 RNA CHKB-DT 下调通过 ALDH2 增强扩张型心肌病。
Circ Res. 2024 Feb 16;134(4):425-441. doi: 10.1161/CIRCRESAHA.123.323428. Epub 2024 Feb 1.
10
Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling.在小鼠肥厚型心肌病(HCM)模型中抑制miR-199a-3p可减轻纤维化重塑。
J Mol Cell Cardiol Plus. 2023 Dec;6:100056. doi: 10.1016/j.jmccpl.2023.100056.